These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4960779)

  • 1. On certain properties and diagnostic-prognostic significance of tubercle bacilli, directly detectable but not culturable.
    Rozniecki J; Tomaszkiewicz L
    Pol Med J; 1966; 5(4):879-84. PubMed ID: 4960779
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the development of drug-resistant tubercle bacilli in experimental animal tuberculosis].
    Yamanouchi T; Sawai A; Hori M
    Kekkaku; 1973 Jul; 48(7):277-95. PubMed ID: 4200057
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the lability of the degree of drug resistance of Mycobacterium tuberculosis strains].
    Belogurova VP
    Antibiotiki; 1967 Aug; 12(8):718-22. PubMed ID: 4968418
    [No Abstract]   [Full Text] [Related]  

  • 4. [Survival of tuberculous bacilli in combined treatments including rifampicin].
    Kreis B; Pretet S
    Rev Tuberc Pneumol (Paris); 1970; 34(3):429-33. PubMed ID: 4994940
    [No Abstract]   [Full Text] [Related]  

  • 5. [Resistance of Mycobacterium tuberculosis, the extent of isoniazid inactivation and blood bacteriostatic activity in chemotherapy of pulmonary tuberculosis].
    Tipp ZI
    Probl Tuberk; 1969; 47(8):76-9. PubMed ID: 4987468
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dynamics of drug resistance and restoration of sensitivity of Mycobacterium tuberculosis isolated from patients].
    Belogurova VP; Navrotskiĭ VV
    Antibiotiki; 1970 May; 15(5):434-7. PubMed ID: 4988018
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on the infection of drug-resistant tubercle bacilli. 3. Experimental studies on the infection of INH highly-resistant tubercle bacilli].
    Osato T; Toyohara M; Aoki M; Hatori H
    Kekkaku; 1968 Nov; 43(11):473-9. PubMed ID: 4975533
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effectiveness, during the 1st year, of 3 treatment durations].
    Krebs A
    Bull Int Union Tuberc; 1974; 49(1):327-32. PubMed ID: 4219731
    [No Abstract]   [Full Text] [Related]  

  • 9. Tuberculous meningitis due to primary drug-resistant Mycobacterium tuberculosis hominis.
    Bonforte RJ; Karpas CM; Gribetz I; Shanzer S
    Pediatrics; 1968 Dec; 42(6):969-75. PubMed ID: 4973145
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug resistance of tubercle bacilli isolated from sputum in previously untreated pulmonary tuberculosis. 3].
    Nakai H; Maekawa N; Nakanishi M; Kawai M; Naito M
    Bull Chest Dis Res Inst Kyoto Univ; 1971 Jan; 4(1):15-24. PubMed ID: 5005481
    [No Abstract]   [Full Text] [Related]  

  • 11. [Phythyvazid-resistance of myobacterium tuberculosis and its clinical importance].
    Belogurova VP; Dargevich VK
    Sov Med; 1966 Mar; 29(3):66-72. PubMed ID: 4967965
    [No Abstract]   [Full Text] [Related]  

  • 12. Course of cases of pulmonary tubercurosis with bacilli resistant to streptmycin, para-aminosalicylic acid and isoniazid and with multiple drug-resistance.
    Oka S
    Sci Rep Res Inst Tohoku Univ Med; 1969 Dec; 16(3):106-9. PubMed ID: 4988512
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of policies of sensitivity testing of tubercle bacilli in Hong Kong.
    Mitchison DA
    BTTA Rev; 1972 Jun; 2(2):34-5. PubMed ID: 4624665
    [No Abstract]   [Full Text] [Related]  

  • 14. Sensitivity to streptomycin, isoniazid and para-aminosalicylic acid of tubercle bacilli from patients with pulmonary tuberculosis in Sri Lanka.
    Pinto MR; Arseculeratne SN; Dasan P; Uragoda CG
    Ceylon Med J; 1982 Jun; 27(2):69-74. PubMed ID: 6819092
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative results of treatment of pulmonary tuberculosis with the compounds of benzoyl-PAS-Ca-isoniazide and streptomycin-isoniazid].
    Favez G; Gonin JD; Gubéran E; de Kalbermatten JP; Vulliémoz P; Willa C
    Schweiz Med Wochenschr; 1969 Feb; 99(5):150-6. PubMed ID: 4974643
    [No Abstract]   [Full Text] [Related]  

  • 16. Consensus: management of tuberculin-positive children without evidence of disease.
    Grossman M; Hopewell PC; Jacobs RF; Kendig EL; Smith MH
    Pediatr Infect Dis J; 1988 Apr; 7(4):243-6. PubMed ID: 3130606
    [No Abstract]   [Full Text] [Related]  

  • 17. [A clinical study on the virulence of INH-resistant tubercle bacilli in the human body].
    Murata A
    Kekkaku; 1967 Aug; 42(8):309-11. PubMed ID: 4966678
    [No Abstract]   [Full Text] [Related]  

  • 18. [Secondary drug sensitivity of tubercle bacilli in chronic sputum-positive tuberculosis patients].
    Telejko Z
    Gruzlica; 1970 Oct; 38(11):1101-4. PubMed ID: 4992233
    [No Abstract]   [Full Text] [Related]  

  • 19. [The critical concentration of clinical rifampicin resistance for tubercle bacilli and the acquirement pattern of rifampicin resistance of tubercle bacilli on Kirchner's semi-liquid agar media].
    Tamura M; Yamazaki A; Tamura T; Takano S; Yamazaki M
    Kekkaku; 1973 Jun; 48(6):247-53. PubMed ID: 4200023
    [No Abstract]   [Full Text] [Related]  

  • 20. [Complex research studies in the testing of the effectiveness of phenaside].
    Sel'tsovskiĭ PP; Irtuganova OA; Slogotskaia LV; Smirnova NS; Moroz AM; Borzenko AS; Spasov AA; Smirnova LA; Dzhura PI; Karpov AV; Ivanovskiĭ VB; Pauker MN; Plemiannikova GI
    Probl Tuberk; 2001; (8):29-31. PubMed ID: 11767386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.